HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

More in this Section

Two men stabbed in Dublin

NBRU want same pay as Luas drivers

SIPTU members of the National Ambulance Service have voted for industrial action

Counsel accuses woman allegedly raped by husband of having motives to 'lie and exaggerate'


You might also like

Today's Stories

Schoolboy sued Adidas over match injury

EU has no policy to accommodate Irish-UK special relationship

LÉ Róisín crew rescue 371 migrants in three Mediterranean operations

Women make up 20% of prisoners

Lifestyle

Alexander Skarsgard feels at home swinging through the trees in new Tarzan movie

Bear Grylls' family history influences explorer's second novel

Some of the basic principals to help you save money

DEBATE: Is Rory McIlroy right not to go to Rio?

More From The Irish Examiner